About 46.27 lakh shares of Zydus Wellness changed hands in the pre-open block deal window on Tuesday, June 17. As much as 7% of the stake in the company changed hands today. The large deal took place at a price of ₹1,900 per share, taking the total transaction amount to ₹879 crore. The stock surged as much 3.7% to its intraday high of ₹1,984 on the National Stock Exchange.
At its intraday high, the stock was nearly 33% above its 52-week low level and over 20% below its 52-week high level. Shares of the company have gained over 7% in the last one year, but have gained only marginally in 2025 so far. However, the stock has gained nearly 9% in the last one month.
After releasing its financial results for the latest quarter, the company also announced a stock split and dividend. It announced a stock split in the ratio of 1:5, which means that one equity share of the company will be split into five. This is the first instance of the company announcing a division of its equity shares. It had also announced a final dividend of ₹6 per share.
Zydus Wellness posted a 15% on year increase in its net profit of ₹172 crore for the fourth quarter of FY25. Revenue for the March quarter increased 17% on year to ₹913 crore. The company’s earnings before interest, tax, depreciation and amortisation (EBITDA) rose 17% on year to ₹190 crore, while its margin expanded to 20.80%.
Earlier this month, another Zydus group entity, Zydus Lifesciences signed a pact to acquire 6% stake in US-based Agenus Inc for around $16mn, marking its entry into the global biologics contract development and manufacturing organisation sector. This will allow the company to access Agenus's biologics manufacturing units in California, US.
